It has been 18 years since a Thailand-based company took a step that almost no one else dared make. Its decision to enter the then-closed economy of Myanmar has since paid off handsomely for Mega Lifesciences.
Newcomers to Myanmar are seeking Mega’s expertise, says Girish Wadhwa, managing director for the country.
Mega today derives about one-third of its revenues from Myanmar, and is in an excellent position to profit from the economic opening of the country and the rising purchasing power of its people.
This article is older than 60 days, which we reserve for our premium members only.You can subscribe to our premium member subscription, here.